1360550-04-4

1360550-04-4 structure

Name: BI 665915
Chemical Name: 2-[4-(3-{(1R)-1-[4-(2-Amino-5-pyrimidinyl)phenyl]-1-cyclopropylethyl}-1,2,4-oxadiazol-5-yl)-1H-pyrazol-1-yl]-N,N-dimethylacetamide
CAS Number: 1360550-04-4
Molecular Formula: C₂₄H₂₆N₈O₂
Molecular Weight: 458.516
Create Date: 2020-01-11 18:29:51
Modify Date: 2024-03-03 18:43:29
BI 665915 is a highly potent, selective, orally active 5-lipoxygenase-activating protein (FLAP) inhibitor with binding IC50 of 1.7 nM; displays no activity against other enzymes and receptors in the leukotriene pathway such as 5-LO, COX-1 and -2, phospholipase A2, LTA4 hydrolase, BLT1, and BLT2 (IC50s>10 uM); shows functional inhibition of LTB4 production in human whole blood (IC50=45 nM); demonstrates a dose-dependent DMPK relationship and inhibition of LTB4production in vivo.

Name	2-[4-(3-{(1R)-1-[4-(2-Amino-5-pyrimidinyl)phenyl]-1-cyclopropylethyl}-1,2,4-oxadiazol-5-yl)-1H-pyrazol-1-yl]-N,N-dimethylacetamide
Synonyms	MFCD28902241 1H-Pyrazole-1-acetamide, 4-[3-[(1R)-1-[4-(2-amino-5-pyrimidinyl)phenyl]-1-cyclopropylethyl]-1,2,4-oxadiazol-5-yl]-N,N-dimethyl- 2-[4-(3-{(1R)-1-[4-(2-Amino-5-pyrimidinyl)phenyl]-1-cyclopropylethyl}-1,2,4-oxadiazol-5-yl)-1H-pyrazol-1-yl]-N,N-dimethylacetamide

Description	BI 665915 is a highly potent, selective, orally active 5-lipoxygenase-activating protein (FLAP) inhibitor with binding IC50 of 1.7 nM; displays no activity against other enzymes and receptors in the leukotriene pathway such as 5-LO, COX-1 and -2, phospholipase A2, LTA4 hydrolase, BLT1, and BLT2 (IC50s>10 uM); shows functional inhibition of LTB4 production in human whole blood (IC50=45 nM); demonstrates a dose-dependent DMPK relationship and inhibition of LTB4production in vivo.
References	References 1. Takahashi H, et al. J Med Chem. 2015 Feb 26;58(4):1669-90. View Related Products by Target FLAP